| Cat. No. |
Product Name |
Information |
| PC-35463 |
CKD-519
|
CKD-519 (Rocacetrapib, CKD519) is a potent, selective cholesteryl ester transfer protein (CETP) inhibitor, inhibits the CETP-mediated transfer of cholesteryl ester in human serum with IC50 of 2.3 nM. |
| PC-63563 |
BMS-795311
|
BMS-795311 is a potent and orally available CETP inhibitor with IC50 of 3.8 nM, inhibits cholesteryl ester (CE) transfer with IC50 of 0.22 uM. |
| PC-63559 |
Obicetrapib
|
Obicetrapib (AMG-899, TA-8995, DEX-001) is a potent, selective and orally active cholesteryl ester transfer protein (CETP) inhibitor for treatment of dyslipidaemia. |
| PC-43496 |
Evacetrapib
|
Evacetrapib (LY2484595) is a potent and selective inhibitor of cholesteryl ester transfer protein (CETP) with IC50of 5.5 nM for human recombinant CETP protein. |
| PC-42893 |
Anacetrapib
|
Anacetrapib (MK 0859) is a potent, orally active cholesteryl ester transfer protein (CETP) inhibitor with IC50 of 7.9 nM and 11.8 nM for rhCETP and C13S CETP mutant, respectively. |
| PC-42892 |
Torcetrapib
|
Torcetrapib (CP-529414) is a potent cholesteryl ester transfer protein (CETP) inhibitor with IC50 of 37 nM. |
| PC-62014 |
TAP-311
|
TAP-311 is a novel potent and selective CETP inhibitor with plasma IC50 of 62 nM. |
